Winfrey started taking GLP-1 medication in 2023, then took a one-year break from 2024 to 2025
In addition to blood glucose level management, many of these have been shown to be effective in lowering weight
The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes
The Treat2Complete Advantage LightRx integrates these treatments through our Treat2Complete 12-week program , which combines two or more technologies for comprehensive body transformation
If youre unsure how much you should be drinking, what fluids are best, or how to stay hydrated when your appetite is low, you're not alone